Oncology AI providing the edge against cancer? The global R&D pipeline is dominated by potential treatments in oncology and this is also where the investment is flowing.
Partner Content Partner Content PRISYM ID Achieves Zebra Technologies Validation PRISYM ID Achieves Zebra Technologies Validation
Patients 2021 in review: Building the framework of a patient-centric ... Patient centricity and patient engagement have been hot topics in pharma for some time – but buzz words do not always translate into concrete action.
Digital Re-envisioning mental health treatment using clinical VR Skip Rizzo, PhD, research director for medical virtual reality at the University of Southern California's Institute for Creative Technologies (USC ICT), tells us how its virtual reality (VR
Partner Content Partner Content How Label Management Solutions Can Help CDMOS Grow Their In-... HOW LABEL MANAGEMENT SOLUTIONS CAN HELP CDMOS GROW
Partner Content Partner Content Poor Glycaemic Control and Tooth Loss Study Poor Glycaemic Control and Tooth Loss Study
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
